Announcement

Cytosponge Offers Minimally Invasive Screening Option for Barrett’s Esophagus (03-26-2015)
Screening for Barrett’s esophagus with a new device called a Cytosponge is accurate compared to endoscopy but less expensive and easier on patients. These findings were reported in the journal PLoS Medicine. Barrett’s... Continue Reading

Pacritinib May Be Effective against Myelofibrosis without Risk of Myelosuppression (03-25-2015)
The investigational agent pacritinib appears active against myelofibrosis without the risk of myelosuppression, a common side effect of many drugs used to treat myelofibrosis and other myeloproliferative... Continue Reading

Herceptin Superior to Tykerb for Treatment of HER2-positive Breast Cancer (03-24-2015)
In patients with human epidermal growth factor receptor (HER2)–positive advanced breast cancer, the combination of Herceptin® (trastuzumab) plus a taxane resulted in delayed time to cancer progression... Continue Reading

Anne Arundel Medical Center

Please click here to visit the DeCesaris Cancer Institute website

The DeCesaris Cancer Institute and AAMC Oncology and Hematology are now QOPI (Quality Oncology Practice Initiative) Certified. This demonstrates a commitment to excellence and ongoing quality improvement.
The goals of the QOPI Certification Program are:

1. Promote the highest quality cancer care as defined by the clinician experts.
2. Provide a trusted solution to satisfy external demand for quality activities.
3. Reduce redundant programs or requirements for oncology practices, including health plan programs.